THRD logo

Third Harmonic Bio, Inc. Common Stock


THRD: Third Harmonic Bio Inc is a clinical-stage company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases.. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival.


Show THRD Financials

Consumer Interest
SEC Filings

Recent trades of THRD by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by THRD's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Crystalline forms of a selective c-kit kinase inhibitor Sep. 26, 2023
  • Patent Title: Pharmaceutical compositions of a selective c-kit kinase inhibitor and methods for making and using same Sep. 05, 2023
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of THRD in WallStreetBets Daily Discussion


Recent insights relating to THRD

CNBC Recommendations

Recent picks made for THRD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in THRD

Corporate Flights

Flights by private jets registered to THRD